Upstate Active Clinical Trials
Study Title:
Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to YF-VAX in AdultsWhat is the purpose of the study?
This study is looking to describe the safety and tolerability of a novel Yellow Fever vaccine. Yellow Fever is a mosquito-borne disease that is caused by a virus that causes a wide range of health problems, from mild symptoms to severe illness. Yellow Fever is widespread in sub-Saharan Africa and tropical South America and continues to be a significant health problem to many residents and non-vaccinated travelers of these regions. This vaccine is expected to help prevent Yellow Fever as there is no specific treatment for it.Upstate Institutional Review Board (IRB) Number:
1737734Study/Protocol ID:
VYF02Study Phase:
IIPatient Age Group:
AdultsPrincipal Investigator:
Kristopher M PaolinoWhat is involved if I participate?
- How long is the study?
10 visits over 5 years - Is transportation provided or reimbursed?
Yes - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
Collection of medical history, physical exam, blood draw. May receive trial vaccine or currently approved YF-VAX.
Where will the study take place?
Upstate Community CampusOther Information:
Contact Keely Terrillion315-464-9869
Trials@upstate.edu
Who can I contact for more information?
Name: Kianna Ripich
Phone: 315-464-6488
Email: ripichk@upstate.edu